SUCLG1

Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial · P53597 · SUCLG1 on Sugi Atlas →

0 patent compounds predicted against SUCLG1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SUCLG1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails PHASE4COMPLETED
Dental Fluorosis Risk by the Use of Acidulated Fluoride Dentifrice PHASE4COMPLETED
Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia PHASE2/PHASE3COMPLETED
Use of Essential Oils as Natural Therapies PHASE3COMPLETED
To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis PHASE2UNKNOWN
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study PHASE2COMPLETED
TDT 067 Open Label Multi-Dose Onychomycosis Study PHASE2COMPLETED
Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC PHASE1COMPLETED
Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis PHASE1UNKNOWN
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases PHASE1COMPLETED
Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole PHASE1UNKNOWN
Clubfoot DNA Repository nanCOMPLETED
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population nanCOMPLETED
IL-17 Role in Variants of Psoriasis nanCOMPLETED
Exome Evaluation in Patients Living With Diabetes Complicated by Charcot Neuroarthropathy. nanCOMPLETED
Genetic Identification (ID) of Segmental Dysplastic Nevi nanWITHDRAWN
Neurological and Psychological Assessment of Neurocutaneous Syndromes in Upper Egypt Children nanUNKNOWN
Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Nails nanCOMPLETED
Clinical Trial of Topical ABL01 Treatment of Onychomycosis nanCOMPLETED
Chest Wall Deformities in Children - Epidemiological Data nanCOMPLETED
Screening for Genes in Patients With Poikiloderma nanCOMPLETED
GWAS in a Small Group of Metabolically Healthy Obese White Adults nanCOMPLETED
Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox nanNOT_YET_RECRUITING
Clinical Aspect of Erosive Pustular Dermatosis of the Leg nanCOMPLETED
Analysis and Measurement of Nail Morphology nanACTIVE_NOT_RECRUITING
Construction of a Reference Corridor to Assess the Value of Combining Innovative Morphological and Functional Analysis Techniques in Pediatric Patient Care Based on Different Pathological Models nanNOT_YET_RECRUITING
Genetic Analysis of Familial Melanoma nanCOMPLETED
A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis nanCOMPLETED
Hemostasis Assesment After Application of Lyophilisate Collagen in Nail Surgery nanUNKNOWN
A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SUCLG1 binder may also engage these)

ProteinNameSimilarity
P13086 1.000 P13086 →
O19069 1.000 O19069 →
Q9WUM5 0.999 Q9WUM5 →
Q58DR8 0.997 Q58DR8 →
Q94522 0.993 Q94522 →
Q8GTQ9 0.991 Q8GTQ9 →
Q8LAD2 0.988 Q8LAD2 →
Q6DQL1 0.987 Q6DQL1 →
Q6ZL94 0.985 Q6ZL94 →
P68209 0.985 P68209 →
P53596 0.985 P53596 →
B3FHT4 0.981 B3FHT4 →
Q9YGD2 0.980 Q9YGD2 →
P36967 0.980 P36967 →
O13750 0.974 O13750 →
Q1RH56 0.973 Q1RH56 →
Q92I22 0.972 Q92I22 →
Q9P727 0.971 Q9P727 →
Q9AKE1 0.970 Q9AKE1 →
O08371 0.970 O08371 →
W5PFI3 0.969 W5PFI3 →
P53591 0.969 P53591 →
Q4ULQ8 0.967 Q4ULQ8 →
Q61941 0.967 Q61941 →
P11024 0.966 P11024 →
P32296 0.966 P32296 →
NNT NAD(P) transhydrogenase, mitochondrial 0.965 landscape →
A7M6E8 0.965 A7M6E8 →
Q8BMF3 0.963 Q8BMF3 →
Q29554 0.963 Q29554 →